Healthcare platform Agilon targets valuation of up to $9b

NEW YORK: Agilon Health is aiming for a valuation of up to US$9 billion in… read more

Anti-inflammatory product order boost for MGC

PERTH: Trailblazing bio-pharma company MGC Pharmaceuticals, who specialises in the development and production of phytocannabinoid-derived… read more

Singular builds reconstructive surgery 3D capability

PERTH: Singular Health has moved to strengthen its suite of medical imaging products by entering… read more

FDA approves self-injectable formulation of Xolair

SEATTLE: The FDA has approved a self-injectable formulation of Xolair for appropriate patients with moderate… read more